AVIVA PLC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AVIVA PLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$26,723,023
+4.4%
31,010,000
+3.4%
0.11%
+7.7%
Q2 2023$25,588,230
+0.3%
30,000,0000.0%0.10%
-10.3%
Q1 2023$25,517,490
+2.5%
30,000,0000.0%0.12%
-4.9%
Q4 2022$24,891,000
-19.0%
30,000,000
-21.7%
0.12%
-31.1%
Q3 2022$30,720,000
+0.7%
38,300,0000.0%0.18%
+9.3%
Q2 2022$30,510,000
-5.0%
38,300,0000.0%0.16%
+0.6%
Q1 2022$32,126,00038,300,0000.16%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders